PMID: 6104172Jun 28, 1980Paper

ECT for schizophrenia

Lancet
P Taylor, J J Fleminger

Abstract

Electroconvulsive therapy (ECT) in the treatment of schizophrenia was evaluated in a double-blind trial; the clinical change after ECT was compared with that after a treatment procedure identical to it but for two exceptions--no electricity was used and no convulsion was induced. All patients had paranoid schizophrenia according to Present State Examination criteria and all received standard doses of neuroleptics for at least 2 weeks before random assignment to the two groups. 20 patients completed the trial: 10 had ECT and 10 were in the control group. Treatment was given three times a week, with a minimum of eight treatments and a maximum of twelve. Clinical change was assessed by the Comprehensive Psychiatric Rating Scale. Both groups improved but the improvement of patients receiving ECT was significantly greater than that of controls both after six treatments (p=0.02) and at the end of treatment (p=0.004). Thus the group receiving ECT gained a clear and early advantage compared with the control group, although by 16 weeks there was little difference between the two groups. Possible reasons for this are discussed.

References

Mar 1, 1978·Acta Psychiatrica Scandinavica·K Planansky, R Johnston
Jan 1, 1974·Journal of Psychiatric Research·J M Davis
Jul 1, 1973·The British Journal of Psychiatry : the Journal of Mental Science·D R DoongajiS Ravindranath
Oct 1, 1970·The British Journal of Psychiatry : the Journal of Mental Science·M F el-IslamM E Erfan
Apr 1, 1956·The American Journal of Psychiatry·G A ULETTG C GLESER
May 1, 1959·A.M.A. Archives of Neurology and Psychiatry·N Q BRILLR A RICHARDS
Jun 1, 1961·Archives of General Psychiatry·A T BECKJ ERBAUGH
Apr 1, 1964·The American Journal of Psychiatry·R T CHILDERS

❮ Previous
Next ❯

Citations

Jan 1, 1989·The Psychiatric Quarterly·S J Bartels, R E Drake
Jul 1, 1985·Biological Psychiatry·C Van Valkenburg, P J Clayton
Jan 1, 1990·Biological Psychiatry·B H King, E H Liston
Feb 27, 1993·Lancet·E C Johnstone
Jan 1, 1996·European Psychiatry : the Journal of the Association of European Psychiatrists·A StevensG Buchkremer
Dec 13, 2001·Psychiatry Research·W Chanpattana, M L Chakrabhand
Jun 3, 1982·The New England Journal of Medicine·J L Brown
Jul 19, 1984·The New England Journal of Medicine·R R Crowe
Jul 21, 2011·Indian Journal of Psychiatry·Vivek H PhutaneB N Gangadhar
Jan 28, 1987·The New Zealand Medical Journal·L Shenkin
Apr 14, 2011·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Iannis M ZervasCostantin R Soldatos
Apr 23, 2005·The Cochrane Database of Systematic Reviews·P Tharyan, C E Adams
Dec 14, 2004·Harvard Review of Psychiatry·Dost Ongür, Stephan Heckers
Mar 20, 2019·The Cochrane Database of Systematic Reviews·Diarmid Jm SinclairClive E Adams
Mar 7, 2006·Clinical Neuropharmacology·Beata J Havaki-KontaxakiConstantin R Soldatos
Jan 1, 1986·Annals of the New York Academy of Sciences·T J Crow, E C Johnstone
Feb 17, 2011·Epidemiologia e psichiatria sociale·John Read, Richard Bentall
Jun 1, 1994·The British Journal of Psychiatry : the Journal of Mental Science·S SikdarH Singh
Apr 1, 1994·The British Journal of Psychiatry : the Journal of Mental Science·C Thompson
May 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·D Dodwell, D Goldberg
Aug 1, 1987·The British Journal of Psychiatry : the Journal of Mental Science·K R Abraham, P Kulhara
Jan 1, 1988·The British Journal of Psychiatry : the Journal of Mental Science·S J CooperD J King
Oct 1, 1981·The British Journal of Psychiatry : the Journal of Mental Science·R E Kendell
Aug 31, 2001·The Journal of ECT·W Chanpattana, M L Chakrabhand
May 21, 2005·The Journal of ECT·Raphael J Braga, Georgios Petrides
Nov 1, 1986·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·B A Martin
Apr 1, 1987·The British Journal of Psychiatry : the Journal of Mental Science·M Fink
Feb 1, 1985·The British Journal of Psychiatry : the Journal of Mental Science·S BrandonS Wellstood-Eason
Dec 17, 2010·Expert Review of Neurotherapeutics·Hazem Shoirah, Hesham M Hamoda
Aug 1, 1982·British Journal of Clinical Pharmacology·P A DixonR Makanjuola
Dec 1, 1984·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·B A MartinH B Kedward
Jan 1, 1986·Annals of the New York Academy of Sciences·M Hamilton
Dec 1, 1992·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·M W Enns, J P Reiss
Apr 1, 1993·The British Journal of Psychiatry : the Journal of Mental Science·P J Saju, K S Jacob
Oct 16, 1989·The Medical Journal of Australia·N A KeksD L Copolov
Sep 2, 1985·The Medical Journal of Australia·F T Varghese, B S Singh
Jun 14, 2019·Molecular Neuropsychiatry·Sana A AliRaphael J Braga

❮ Previous
Next ❯

Related Concepts

Related Feeds

Benign Rolandic Epilepsy

Benign Rolandic epilepsy is a partial idiopathic epilepsy of childhood presenting with a nocturnal seizure and with a typical EEG showing centrotemporal spike and multifocal or generalized sharp slow waves. Here is the latest research.

Catatonic Schizophrenia

Catatonia is a psychomotor symptom in which patients present with stupor, although catatonic excitement may also present at the other end of the spectrum. Catatonia has been historically associated with schizophrenia although it is also associated with other neuropsychiatric disorders. Find the latest research on catatonic schizophrenia here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

The British Journal of Psychiatry : the Journal of Mental Science
R Levy, R Jacoby
The British Journal of Psychiatry : the Journal of Mental Science
D I TemplerG Armstrong
© 2021 Meta ULC. All rights reserved